Ghosh A - Search Results

1

Persistent gamma delta T-cell dysfunction in chronic HCV infection despite direct-acting antiviral therapy induced cure.

Ghosh A, Mondal RK, Romani S, Bagchi S, Cairo C, Pauza CD, Kottilil S, Poonia B. Ghosh A, et al. J Viral Hepat. 2019 Sep;26(9):1105-1116. doi: 10.1111/jvh.13121. Epub 2019 May 26. J Viral Hepat. 2019. PMID: 31074195 Free PMC article.

2

Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients.

Kim JH, Ghosh A, Ayithan N, Romani S, Khanam A, Park JJ, Rijnbrand R, Tang L, Sofia MJ, Kottilil S, Moore CB, Poonia B. Kim JH, et al. Among authors: ghosh a. Sci Rep. 2020 Feb 4;10(1):1835. doi: 10.1038/s41598-020-58870-2. Sci Rep. 2020. PMID: 32020034 Free PMC article.

3

Publisher Correction: Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients.

Kim JH, Ghosh A, Ayithan N, Romani S, Khanam A, Park JJ, Rijnbrand R, Tang L, Sofia MJ, Kottilil S, Moore CB, Poonia B. Kim JH, et al. Among authors: ghosh a. Sci Rep. 2020 Mar 31;10(1):5947. doi: 10.1038/s41598-020-62445-6. Sci Rep. 2020. PMID: 32231233 Free PMC article.

4

Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal.

Ghosh A, Romani S, Kottilil S, Poonia B. Ghosh A, et al. Int J Mol Sci. 2020 Oct 10;21(20):7473. doi: 10.3390/ijms21207473. Int J Mol Sci. 2020. PMID: 33050486 Free PMC article. Review.

5

Short-duration treatment with the novel non-nucleoside inhibitor CDI-31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open-label study.

Chua JV, Ntem-Mensah A, Abutaleb A, Husson J, Mutumbi L, Lam KW, Ghosh A, Romani S, Poonia B, Lee S, Luz Pascual M, Frumkin LR, Kottilil S. Chua JV, et al. Among authors: ghosh a. J Med Virol. 2021 Jun;93(6):3752-3760. doi: 10.1002/jmv.26652. Epub 2020 Nov 22. J Med Virol. 2021. PMID: 33150966 Free PMC article. Clinical Trial.

6

Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans.

Ayithan N, Ghosh A, Dwivedi A, Wallin JJ, Tan SK, Chen D, Kottilil S, Poonia B. Ayithan N, et al. Among authors: ghosh a. Viruses. 2021 Nov 30;13(12):2400. doi: 10.3390/v13122400. Viruses. 2021. PMID: 34960669 Free PMC article. Clinical Trial.

7

Persistent CD38 Expression on CD8 + T Lymphocytes Contributes to Altered Mitochondrial Function and Chronic Inflammation in People With HIV, Despite ART.

Mathur P, Kottilil S, Pallikkuth S, Frasca D, Ghosh A. Mathur P, et al. Among authors: ghosh a. J Acquir Immune Defic Syndr. 2022 Dec 1;91(4):410-418. doi: 10.1097/QAI.0000000000003080. J Acquir Immune Defic Syndr. 2022. PMID: 36000933 Free PMC article.

8

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection.

Price AS, Nelson AK, Ghosh A, Kottilil S, Chua JV. Price AS, et al. Among authors: ghosh a. J Med Virol. 2023 Jan;95(1):e28105. doi: 10.1002/jmv.28105. Epub 2022 Sep 12. J Med Virol. 2023. PMID: 36045503 Free PMC article. Clinical Trial.

9

CD38: an ecto-enzyme with functional diversity in T cells.

Ghosh A, Khanam A, Ray K, Mathur P, Subramanian A, Poonia B, Kottilil S. Ghosh A, et al. Front Immunol. 2023 Apr 27;14:1146791. doi: 10.3389/fimmu.2023.1146791. eCollection 2023. Front Immunol. 2023. PMID: 37180151 Free PMC article.

10

Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways.

Khanam A, Ghosh A, Chua JV, Kottilil S. Khanam A, et al. Among authors: ghosh a. J Transl Med. 2023 Apr 21;21(1):271. doi: 10.1186/s12967-023-04104-8. J Transl Med. 2023. PMID: 37081509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,483 results

Search Page